GILEAD SCIENCES INC Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | M | 26.62 | 20,000 | 532,300 | 45,000 | |
| Feb 28 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 84.05 | 20,000 | 1,681,070 | 0 | 20 K to 0 (-100.00 %) |
| Feb 28 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 26.62 | 20,000 | 532,300 | 20,000 | 0 to 20 K |
| Feb 25 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | M | 23.60 | 5,000 | 118,000 | 0 | |
| Feb 25 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 83.24 | 5,000 | 416,218 | 49,832 | 54.8 K to 49.8 K (-9.12 %) |
| Feb 25 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Buy | M | 23.60 | 5,000 | 118,000 | 54,832 | 49.8 K to 54.8 K (+10.03 %) |
| Feb 21 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 83.36 | 968 | 80,692 | 49,832 | 50.8 K to 49.8 K (-1.91 %) |
| Feb 21 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 21.94 | 968 | 21,243 | 50,800 | 49.8 K to 50.8 K (+1.94 %) |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 14.50 | 90,000 | 1,305,225 | 0 | |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 82.75 | 3,900 | 322,723 | 68,124 | 72 K to 68.1 K (-5.41 %) |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 81.99 | 13,586 | 1,113,885 | 72,024 | 85.6 K to 72 K (-15.87 %) |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 81.17 | 72,514 | 5,885,613 | 85,610 | 158.1 K to 85.6 K (-45.86 %) |
| Feb 19 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 14.50 | 90,000 | 1,305,225 | 158,124 | 68.1 K to 158.1 K (+132.11 %) |
| Feb 21 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | M | 22.02 | 19,068 | 419,782 | 0 | |
| Feb 21 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 82.89 | 11,892 | 985,734 | 0 | 11.9 K to 0 (-100.00 %) |
| Feb 21 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Sell | S | 83.51 | 7,176 | 599,256 | 11,892 | 19.1 K to 11.9 K (-37.63 %) |
| Feb 21 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 22.02 | 19,068 | 419,782 | 19,068 | 0 to 19.1 K |
| Feb 18 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | G | 22.02 | 19,068 | 419,782 | 19,068 | |
| Feb 18 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | G | 26.62 | 65,000 | 1,729,975 | 65,000 | |
| Feb 18 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | G | 22.02 | 19,068 | 419,782 | 0 | |
| Feb 18 2014 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | G | 26.62 | 65,000 | 1,729,975 | 0 | |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 1,406,258 | |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 81.83 | 500 | 40,915 | 4,256,267 | 4.3 M to 4.3 M (-0.01 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 81.17 | 32,725 | 2,656,223 | 4,256,767 | 4.3 M to 4.3 M (-0.76 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 80.21 | 49,000 | 3,930,226 | 4,289,492 | 4.3 M to 4.3 M (-1.13 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 79.05 | 58,400 | 4,616,724 | 4,338,492 | 4.4 M to 4.3 M (-1.33 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,396,892 | 4.3 M to 4.4 M (+3.30 %) |
| Feb 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 21.58 | 16,728 | 360,907 | 24,632 | |
| Feb 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 79.10 | 16,728 | 1,323,198 | 15,133 | 31.9 K to 15.1 K (-52.50 %) |
| Feb 12 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 21.58 | 16,728 | 360,907 | 31,861 | 15.1 K to 31.9 K (+110.54 %) |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | D | 0.00 | 11,130 | 0 | 153,931 | |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 0.00 | 2,480 | 0 | 2,480 | |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | EVP, Commercial Ope ... | Option Exercise | A | 80.65 | 8,250 | 665,363 | 8,250 | |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 21.58 | 31,000 | 668,825 | 58,367 | |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 81.35 | 336 | 27,332 | 85,516 | 85.9 K to 85.5 K (-0.39 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 80.37 | 1,200 | 96,449 | 85,852 | 87.1 K to 85.9 K (-1.38 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 79.28 | 464 | 36,785 | 87,052 | 87.5 K to 87.1 K (-0.53 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 81.15 | 22,497 | 1,825,548 | 87,516 | 110 K to 87.5 K (-20.45 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 80.27 | 5,438 | 436,523 | 110,013 | 115.5 K to 110 K (-4.71 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 79.27 | 3,065 | 242,955 | 115,451 | 118.5 K to 115.5 K (-2.59 %) |
| Feb 05 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 21.58 | 31,000 | 668,825 | 118,516 | 87.5 K to 118.5 K (+35.42 %) |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | A | 80.65 | 57,180 | 4,611,567 | 57,180 | |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | A | 80.65 | 64,910 | 5,234,992 | 64,910 | |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | A | 80.65 | 52,540 | 4,237,351 | 52,540 | |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | A | 80.65 | 162,260 | 13,086,269 | 162,260 | |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 80.65 | 15,460 | 1,246,849 | 60,280 | |
| Feb 04 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Option Exercise | A | 80.65 | 44,820 | 3,614,733 | 44,820 |